| Overview |
| bsm-90235r-50µL |
| GARS Recombinant Antbody Kit (KD-Validated) |
| WB, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human GARS |
| 701-739/739 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 2617 |
| P41250 |
| GARS1; Glycyl-TRNA Synthetase 1; GlyRS; DSMAV; SMAD1; GARS; Diadenosine Tetraphosphate Synthetase; Charcot-Marie-Tooth Neuropathy 2D; Glycyl-TRNA Synthetase; Glycine--TRNA Ligase; Ap4A Synthetase; EC 6.1.1.14; CMT2D; Charcot-Marie-Tooth Neuropathy Neuronal Type D; Glycine TRNA Ligase; AP-4-A Synthetase; EC 2.7.7.-; HMN5A; SMAJI; GLYRS; HMN5 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| IC |
1:1000 |